Collplant plans clinical trials for dermal filler and advances regenerative implants
Q4 2024 Management View CEO Yehiel Tal highlighted advancements in CollPlant's proprietary photocurable dermal filler, emphasizing its potential as a game-changer in the $6.3 billion market for ...
Emily Standley Allard on MSN2mon
Your Guide to Facial Fillers: Types, Uses, and What to Expect
We all want to maintain our youthful appearance for as long as we can. Facial fillers, also known as dermal fillers, have ...